SOTIO Strengthens Management Team with Appointment of Robyn Hunter as Chief Financial Officer
CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — SOTIO Biotech, a clinical stage immuno-oncology company…
News
SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology
BILLERICA, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
Mereo BioPharma Reports Clinical Update and Interim Biomarker Analysis Presented at ESMO 2022 from ACTIVATE Phase 1b/2 Open Label Study of Etigilimab (Anti-TIGIT Antibody MPH-313) plus Nivolumab (Anti-PD-1 Antibody) in Solid Tumors
Data support further evaluation of PVR, CD226, and TIGIT as potential biomarkers of enrichment for…
Arbor Biotechnologies Named One of Fierce Biotech’s “Fierce 15” Companies of 2022
CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — Arbor Biotechnologies today announced that Fierce Biotech…
Vaxxinity Initiates Rolling Submission for UB-612 COVID-19 Vaccine with MHRA (UK)
DALLAS, Sept. 12, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering…
MediWound’s NexoBrid® Highlighted in 45 Posters and Presentations at the 19th European Burns Association Congress
YAVNE, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a fully integrated biopharmaceutical…
Mersana Therapeutics Announces FDA Fast Track Designation Granted to XMT-1660 for the Treatment of Triple-Negative Breast Cancer
XMT-1660 currently being studied in a Phase 1 trial enrolling patients with breast, endometrial and…
Akari Therapeutics Announces $12.75 Million Registered Direct Offering
NEW YORK and LONDON, Sept. 12, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
Hepion Pharmaceuticals Announces Initiation of Dosing in Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial
– Hepion Collaborates with HepQuant and Summit Clinical Research to Evaluate Rencofilstat’s Impact on Hepatic…
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
NDA Submission for Nyxol Eye Drops in First Indication on Track for Late 2022 FARMINGTON…
Selecta Biosciences to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Spacee Launches HoverTouch™ Wall, a New Interactive Way for Retailers to Engage with Customers In-Store and Lift Sales
HoverTouch™ Wall Spacee Launches HoverTouch™ Wall, a New Interactive Way for Retailers to Engage with…
Inuvo’s IntentKey™ Achieves 469% Increase in Organic Searches and 73% Increase in Leads in a Cookie-Free Environment
IntentKey™ successfully accesses Safari and Firefox inventory in a cookie-free environment LITTLE ROCK, Ark., Sept….
Voxtur AOL® Now Offered by Multiple Lenders Nationwide
TORONTO and TAMPA, Fla., Sept. 12, 2022 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR;…
Orezone Pours First Gold at the Bomboré Mine
Photo of first gold pour Orezone’s Burkina Faso Country Manager, Ousseni Derra and VP, Project…
Shell Chooses Driivz’s EV charging and smart energy management platform
Driivz EV charging and smart energy management platform to support further European EV charging growth…
TRON and Wintermute Reach Strategic Partnership
Geneva, Switzerland–(Newsfile Corp. – September 12, 2022) – TRON is thrilled to announce that Wintermute…
JZZ Technologies, Inc. and TGI Subsidiary AdventGalaxy Form Metaverse-Based Media Platform Joint Venture
Anderson, South Carolina–(Newsfile Corp. – September 12, 2022) – Active Lifestyle Media parent company JZZ…
FDA Awards $2.6 Million Grant for Expanded Study of Soligenix’s Hybryte(TM) for CTCL
New York, New York–(Newsfile Corp. – September 12, 2022) – PCG Digital — Late-stage biopharmaceutical…
Therma Bright Provides Update on FDA EUA Review Process
Toronto, Ontario–(Newsfile Corp. – September 12, 2022) – Therma Bright Inc. (TSXV: THRM) (“Therma” or…